Andrew Simpson has been active in trading shares of Heart Test Laboratories, participating in several insider trades recently. Notably, he made trades worth $25.92K on August 1, 2024, and another for $22.48K on September 1, 2024. His stock holdings have...

Andrew Simpson has been active in trading shares of Heart Test Laboratories, participating in several insider trades recently. Notably, he made trades worth $25.92K on August 1, 2024, and another for $22.48K on September 1, 2024. His stock holdings have seen fluctuations, indicating a significant engagement with the company's financial health. At present, a portion of his wealth is tied to Heart Test Laboratories, and as of 2022, his financial stake was highlighted by the company's $1.5 million in convertible promissory notes that converted to shares upon IPO. His trading activity suggests he is closely monitoring the market and may be preparing for future developments as the company progresses toward FDA clearance.